Selected Grants
Investigating the development and contribution of individual plasma B cells to broad HIV serum neutralization
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2026 - 2031Translating germline-targeting HIV Env SOSIP immunization of infants: targeting bnAbs in early life
ResearchPrincipal Investigator · Awarded by Weill Cornell Medicine · 2025 - 2030Genetic and Structural Basis for Virus Neutralization
ResearchInvestigator · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2029SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
ResearchInvestigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027DMS/NIGMS 1: Challenges in Stochastic Modeling and Computation for Sequential Vaccine Design
ResearchCo-Principal Investigator · Awarded by National Science Foundation · 2024 - 2027Structural Insights into Transient States in HIV-1 Broadly Neutralizing Antibody Interactions
ResearchCo Investigator · Awarded by National Institutes of Health · 2026 - 2027A T and B Cell Therapeutic Countermeasure to Functionally Cure Lentiviral Infection
ResearchInvestigator · Awarded by National Institutes of Health · 2026 - 2027SHIV/HIV Env-antibody coevolution as a molecular guide to V3 glycan targeted vaccine design
ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2022 - 2027CIVICs Component A Year 7 - Option 6
ResearchBioinformatics & Data Mgmt Core Head · Awarded by National Institutes of Health · 2019 - 2026Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-naive and -experienced Individuals
ResearchPrincipal Investigator · Awarded by Henry M. Jackson Foundation · 2023 - 2026HIVRAD Project 1: Age-related impact on early life B cell lineage-designed SOSIP HIV Env vaccination
ResearchPrincipal Investigator · Awarded by Weill Cornell Medicine · 2020 - 2026Natural killer cell regulation of the germinal center HIV neutralizing antibody response
ResearchCo Investigator · Awarded by The Children's Mercy Hospital · 2019 - 2025Duke DARPA Pandemic Prevention Platform (P3)
ResearchInvestigator · Awarded by Defense Advanced Research Projects Agency · 2017 - 2024Immunogen Design of HIV Sequential Envelopes Derived from SHIV-infected Macaques
ResearchInvestigator · Awarded by University of Pennsylvania · 2017 - 2023Clinical and viral characteristics of maternal cytomegalovirus infection among seropositive pregnant women in the United States
ResearchInvestigator · Awarded by National Institutes of Health · 2018 - 2022Combined Hepatitis B and HIV-1 Envelope Infant Vaccination to Augment T cell Help through Enhanced Linked Recognition
ResearchBioinformatics Specialist · Awarded by National Institutes of Health · 2017 - 2022Immunogen Design Strategies To Direct Hiv-1 Broadly Neutralizing Antibody Maturation By Probability-Based Targeting Of Critical Mutations
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2021Project 2: RNA vaccination in early life to induce potent and broad HIV Env-specific antibody responses
ResearchInvestigator · Awarded by Weill Cornell Medicine · 2020 - 2021Validation of the ADAMANT Platform
ResearchInvestigator · Awarded by Ology Bioservices · 2019 - 2020Natural killer cell regulation of the germinal center HIV neutralizing antibody response
ResearchCo Investigator · Awarded by The Children's Mercy Hospital · 2019 - 2019Creation of a bnAbnectin
ResearchInvestigator · Awarded by ViiV Healthcare · 2017 - 2019Critical domains for HIV-1 entry through atypical coreceptor usage
ResearchCo Investigator · Awarded by National Institutes of Health · 2013 - 2016External Relationships
- George Mason University (GMU)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.